Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,171) with videos related to
Page
of 118
Sort By:
The New England Journal of Medicine
|
December 12, 2019
Early High-Dose Vitamin D<sub>3</sub> for Critically Ill, Vitamin D-Deficient Patients
, Adit A Ginde, Roy G Brower, et al.
Internal and Emergency Medicine
|
October 31, 2024
SEPSIGN: early identification of sepsis signs in emergency department
Thomas Lafon, Marie-Angélique Cazalis, Kimberly W Hart, et al.
JAMA Network Open
|
June 29, 2026
Screening for Missed Opportunities for Diagnosis in the ED Using eTriggers and Large Language Models
Clifford M Marks, Sean Gibney, Bryan Stenson, et al.
Cancer Research
|
July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
Takeshi Shimamura, Danan Li, Hongbin Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors
Geoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
Cancer Research
|
October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene
Zhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.
Stigma and Health
|
March 27, 2023
The association between mental health stigma and face emotion recognition in individuals at risk for psychosis
Shaynna N Herrera, Emmett M Larsen, Joseph S Deluca, et al.
Critical Care Explorations
|
December 9, 2024
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis-Study of Treatment's Echocardiographic Mechanisms (CLOVERS-STEM)
Michael J Lanspa, Akram Khan, Patrick G Lyons, et al.
Nature Communications
|
September 23, 2021
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
Panagiotis A Konstantinopoulos, Alexandre André B A da Costa, Doga Gulhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Page
of 118
Search research articles
Search
Showing results (991-1000 of 1,171) with videos related to
Sort By:
Page
of 118
The New England Journal of Medicine
|
December 12, 2019
Early High-Dose Vitamin D<sub>3</sub> for Critically Ill, Vitamin D-Deficient Patients
, Adit A Ginde, Roy G Brower, et al.
Internal and Emergency Medicine
|
October 31, 2024
SEPSIGN: early identification of sepsis signs in emergency department
Thomas Lafon, Marie-Angélique Cazalis, Kimberly W Hart, et al.
JAMA Network Open
|
June 29, 2026
Screening for Missed Opportunities for Diagnosis in the ED Using eTriggers and Large Language Models
Clifford M Marks, Sean Gibney, Bryan Stenson, et al.
Cancer Research
|
July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
Takeshi Shimamura, Danan Li, Hongbin Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2011
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors
Geoffrey I Shapiro, Raoul Tibes, Michael S Gordon, et al.
Cancer Research
|
October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene
Zhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.
Stigma and Health
|
March 27, 2023
The association between mental health stigma and face emotion recognition in individuals at risk for psychosis
Shaynna N Herrera, Emmett M Larsen, Joseph S Deluca, et al.
Critical Care Explorations
|
December 9, 2024
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis-Study of Treatment's Echocardiographic Mechanisms (CLOVERS-STEM)
Michael J Lanspa, Akram Khan, Patrick G Lyons, et al.
Nature Communications
|
September 23, 2021
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
Panagiotis A Konstantinopoulos, Alexandre André B A da Costa, Doga Gulhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250)
Matthew Ingham, Jacob B Allred, Li Chen, et al.
Page
of 118